Helios (HLIO) Form 3 Shows Executive Options, Performance RSUs
Rhea-AI Filing Summary
Jeremy Scott Evans filed an initial Form 3 disclosing beneficial ownership in Helios Technologies, Inc. (HLIO). He directly owns 195 shares of common stock and holds multiple equity awards: stock options to purchase 2,671 and 2,118 shares (with exercise prices of $40.13 and $39.80), performance-based restricted stock units potentially covering up to 836 shares, and several time-based restricted stock unit grants totaling 2,295 RSUs across grant dates in 2024–2025. Vesting and exercise schedules vary: some options vest fully on the third anniversary, performance awards depend on multi-year metrics, and RSUs vest over one-to-three year schedules. The filing includes a remark that the submission was delayed due to obtaining EDGAR Next credentials.
Positive
- Officer holds meaningful equity-based compensation (options and RSUs) aligning incentives with long-term shareholder value
- Performance awards include upside multipliers (up to 225% for performance options and up to 200% for performance RSUs), linking pay to multi-year metrics
Negative
- Form filing was delayed due to administrative issues obtaining EDGAR Next credentials, which could concern timely disclosure practices
Insights
TL;DR: Routine insider disclosure showing officer equity holdings and standard vesting; delayed filing noted but no adverse corporate governance signals in the filing itself.
The Form 3 documents the Chief Accounting Officer's direct ownership of 195 shares and a portfolio of time- and performance-based awards that align his compensation with long-term company performance. Vesting schedules span one to three years and performance awards are tied to committee-approved metrics, indicating governance oversight of incentive design. The delayed filing is disclosed as administrative and lacks further explanation here.
TL;DR: Officer compensation is largely equity-based with mix of time-vested and performance-contingent awards, typical for alignment with shareholder interests.
The disclosure quantifies option grants (2,671 and 2,118 options) with exercise prices near $40 and multiple RSU grants (836 performance-based plus 2,295 time-based RSUs). Performance awards include upside multipliers (up to 225% for options and up to 200% for RSUs) subject to multi-year performance periods, which creates potential variable pay outcomes tied to company results. Vesting/expiration terms are standard for executive incentives.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Performance-Based Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Stock Options granted to reporting person on September 11, 2024; unless earlier forfeited under the terms of the Options, 100% of the options vest and become exercisable on the third anniversary of the grant date. The performance stock options granted to the reporting person on February 27, 2025, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2025 and ending the last day of the fiscal year of 2027, subject to continuous employment with the Company through March 15, 2028. Stock options expire 10 years from the date of grant. The performance based restricted stock units granted to the reporting person on April 1, 2024, which represent the right to receive, following vesting, up to 200% of one share of the Company's Common Stock. The number of shares of Common Stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee over a three-year performance period beginning on the first day of the fiscal year of 2024 and ending on the last day of the fiscal year of 2027. Restricted stock units granted to reporting person on April 1, 2024; unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date. Each RSU represents the right to receive, following vesting, one share of Common Stock. Restricted stock units granted to reporting person on September 11, 2024, 50% of the awards vest and convert into Common Stock on each of the first two anniversaries of the grant date. Restricted stock units granted to reporting person on February 17, 2025; unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date.
